glp-1 nad Power Reset Duo: Berberine & NAD+ Patch Pack by PatchAid Multiple target tissue effects of

GLP-1GIP2 GLP-1 9.5kg4.4kg 1 120,00030,000 / 2 1,80011.2kg5.7kg 710kg 46kg * 710kg 710kg *4012.4kg * 13 12kg kg 45kg 45kg 11kg 406.5kg SUSTAIN0.5mg1.0mg 10 GLP-1 GLP-1 2 * GLP-1 GLP-1GIP GLP-1 GLP-1 GLP-1 GLP-1GLP-1 GLP-1 GLP-1 11 GIP GIPGIP GIP GIPGIP 1722 * 21 40% // // * 1 120,00030,00015,000 123 123 11145 114 12.5mg1INJE800021,100112[INJE8000]1,650/ 11.52 11.52 12.0mg1 11 0.25mg11.0mg0.5 1.0mg14.0mg2 1 / (3) 2 11 GLP-1 1.52 11145 2.5mg 2.5mg 7 7 BMI 1 QA QA * kg * 30 2*72 40.1 * BMI27 6 BMI35 BMI27// 6 6 //

As blood sugar levels rise after eating, the incretins potentiate glucose-dependent insulin secretion from pancreatic -cells and inhibit glucagon secretion from pancreatic -cells

Small amounts of food should be taken in more frequent meals

We prioritize root-cause analysis, using advanced diagnostics to uncover imbalances like hormonal shifts or nutrient deficiencies that contribute to conditions such as fatigue, depression, or weight gain

Tolerable Upper Intake Level (UL)

The overall incidence of nausea appears similar between oral and injectable formulations in clinical trials, affecting approximately 30 to 50 percent of patients starting therapy